Wellington Management Group
CRSP icon

Wellington Management Group’s CRISPR Therapeutics CRSP Stock Holding History

Wellington Management Group’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Buy
34,869
+797
+2% +$42K ﹤0.01% 1588
2025
Q4 		$1.79M Sell
34,072
-2,414
-7% -$145K ﹤0.01% 1621
2025
Q3 		$2.36M Buy
+36,486
New +$2.09M ﹤0.01% 1590
2020
Q4 		– Sell
-518,146
Closed -$43.3M – 1934
2020
Q3 		$43.3M Sell
518,146
-298,249
-37% -$26.5M 0.01% 737
2020
Q2 		$60M Buy
816,395
+107,443
+15% +$6.28M 0.01% 649
2020
Q1 		$30.1M Buy
708,952
+9,616
+1% +$497K 0.01% 767
2019
Q4 		$42.6M Sell
699,336
-280,556
-29% -$15.3M 0.01% 806
2019
Q3 		$40.2M Sell
979,892
-297,197
-23% -$14.2M 0.01% 778
2019
Q2 		$60.2M Sell
1,277,089
-177,541
-12% -$7.1M 0.01% 705
2019
Q1 		$52M Buy
1,454,630
+613,192
+73% +$21.2M 0.01% 721
2018
Q4 		$24M Buy
841,438
+68,965
+9% +$2.4M 0.01% 934
2018
Q3 		$34.3M Sell
772,473
-238,942
-24% -$12.5M 0.01% 921
2018
Q2 		$59.4M Buy
1,011,415
+91,901
+10% +$5.24M 0.01% 733
2018
Q1 		$42M Buy
+919,514
New +$38M 0.01% 838
2017
Q2 		– Sell
-747,450
Closed -$16.3M – 2218
2017
Q1 		$16.3M Buy
747,450
+3,070
+0.4% +$60.3K ﹤0.01% 1097
2016
Q4 		$15M Buy
+744,380
New +$13.9M ﹤0.01% 1083

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group's CRSP Position: Q1 2026 in Review

Wellington Management Group increased its CRISPR Therapeutics (CRSP) stake by 2.3% in Q1 2026, buying an estimated $42K and bringing the position to 34,869 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Wellington Management Group first reported a position in CRSP in Q4 2016 and has held it in 16 quarters since. The position peaked at $60.2M in Q2 2019. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Wellington Management Group held 34,869 shares of CRISPR Therapeutics worth $1.66M as of Q1 2026.
  • Wellington Management Group bought 797 CRISPR Therapeutics shares in Q1 2026, an estimated $42K.
  • CRISPR Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1588 holding.
  • Wellington Management Group first reported a position in CRISPR Therapeutics in Q4 2016 and has held it in 16 quarters since.
  • Wellington Management Group's CRISPR Therapeutics position peaked at $60.2M in Q2 2019.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.